Trial Finder

This field is for validation purposes and should be left unchanged.

Select the cancer type that best matches the information you have. The more specific the cancer type, the better focused your results.

Start by typing in the first few letters of the cancer type you are searching for to narrow down the list. The cancer types are listed alphabetically, and some have multiple options. If you aren’t sure about which option best describes the cancer type you’re searching for, that’s okay. For now, select a broader category, such as lung cancer, until you have more detailed information on the cancer type.

Interventional studies are where participants are assigned to groups that receive one or more treatments (interventions) or no treatment. Researchers evaluate the outcomes. The group you are assigned to is determined by the study’s protocol.

Observational studies are where individuals are observed, or certain outcomes are measured. No attempt is made to change the outcome. For example, no treatment is given.

Expanded Access is a program (EAP) that provides investigational therapy that is not available in a clinical trial. It is for patients who have already tried all additional therapies and treatment options. Investigational medicines that are not yet approved by the U.S. Food and Drug Administration (FDA) may be included in these studies and require approval by the doctor and the company providing the medicine.

Selecting all three options may give you the most trial options in your search results.

Interventional clinical trials often have phases. Selecting “Display all trials” will provide the most options. If you want to restrict the results, read the phase descriptions below to determine which you want to consider.

Early Phase 1 trials test if the new treatment affects the body and how.

Phase 1 trials test the treatment’s side effects, delivery, and timing. They also determine the maximum amount of medicine to give, while keeping the side effects acceptable for participants.

Phase 2 trials test whether the treatment works for a certain cancer type or other diseases, such as shrinking a tumor or improving blood test results. The most effective treatment dosing and delivery from Phase 1 are typically used as the starting point. However, some Phase 2 trials adjust the treatment to determine the best response results.

Phase 3 trials test if the new treatment is better than what is currently available, such as which group of patients has better survival rates or fewer side effects. In most cases, treatments move into Phase 3 clinical trials only after they meet the goals of Phase 1 and Phase 2 clinical trials.

Phase 4 trials test the treatment side effects over time after it has been approved by the U.S. Food and Drug Administration (FDA) and is available. Depending on the availability, this treatment may be available to those not participating in a clinical trial.

Select the anticipated age of the person at the time of the trial start date.

Some clinical trials are limited to a specific sex. Clinical trial enrollment forms categorize biological sex as female with XX chromosomes and male with XY chromosomes. We know not everyone identifies as male or female, so you do not need to answer this question to see myTRIAList clinical trial results. This question will be required when enrolling in a trial. We recommend selecting the participant’s sex based on their chromosomes for the most accurate trial search outcome.

Clinical trials usually require in-clinic treatment. Depending on the trial, this could include multiple visits or overnight stays at a cancer clinic, local hospital, or doctor’s office. Enter the city or zip code of the preferred location.

Select the longest distance you are able to travel for a clinical trial. Choosing a longer distance may give you more clinical trial options.

This field is for validation purposes and should be left unchanged.

Optional Section

Sign Up for Trial Talk